Citation: B. Piovesan et al., HUMAN LYMPHOBLASTOID CELL-LINES EXPRESSING MUTANT P53 EXHIBIT DECREASED SENSITIVITY TO CISPLATIN-INDUCED CYTOTOXICITY, Oncogene, 17(18), 1998, pp. 2339-2350
Authors:
BERINSTEIN NL
GRILLOLOPEZ AJ
WHITE CA
BENCEBRUCKLER I
MALONEY D
CZUCZMAN M
GREEN D
ROSENBERG J
MCLAUGHLIN P
SHEN D
Citation: Nl. Berinstein et al., ASSOCIATION OF SERUM RITUXIMAB (IDEC-C2B8) CONCENTRATION AND ANTITUMOR RESPONSE IN THE TREATMENT OF RECURRENT LOW-GRADE OR FOLLICULAR NON-HODGKINS-LYMPHOMA, Annals of oncology, 9(9), 1998, pp. 995-1001
Authors:
DERZKODZULYNSKY LA
BERGER AR
BERINSTEIN NL
Citation: La. Derzkodzulynsky et al., CYTOMEGALOVIRUS RETINITIS AND LOW-GRADE NON-HODGKINS-LYMPHOMA - CASE-REPORT AND REVIEW OF THE LITERATURE, American journal of hematology, 57(3), 1998, pp. 228-232
Citation: Lk. Verkoczy et Nl. Berinstein, ISOLATION OF GENES NEGATIVELY OR POSITIVELY COEXPRESSED WITH HUMAN RECOMBINATION-ACTIVATING-GENE-1 (RAG1) BY DIFFERENTIAL DISPLAY PCR (DD-RT-PCR), Nucleic acids research, 26(19), 1998, pp. 4497-4507
Citation: Lk. Verkoczy et al., HBRAG, A NOVEL B-CELL LINEAGE CDNA-ENCODING A TYPE-II TRANSMEMBRANE GLYCOPROTEIN POTENTIALLY INVOLVED IN THE REGULATION OF RECOMBINATION ACTIVATING GENE-1 (RAG1), European Journal of Immunology, 28(9), 1998, pp. 2839-2853
Authors:
PIZZOFERRATO E
CHU NR
HAWLEY TS
LIEU FHL
BARBER BH
HAWLEY RG
WATTS TH
BERINSTEIN NL
Citation: E. Pizzoferrato et al., ENHANCED IMMUNOGENICITY OF B-CELL LYMPHOMA GENETICALLY-ENGINEERED TO EXPRESS BOTH B7-1 AND INTERLEUKIN-12, Human gene therapy, 8(18), 1997, pp. 2217-2228
Authors:
IWASAKI A
STIERNHOLM BJN
CHAN AK
BERINSTEIN NL
BARBER BH
Citation: A. Iwasaki et al., ENHANCED CTL RESPONSES MEDIATED BY PLASMID DNA IMMUNOGENS ENCODING COSTIMULATORY MOLECULES AND CYTOKINES, The Journal of immunology, 158(10), 1997, pp. 4591-4601
Authors:
ZARRIN AA
FONG I
MALKIN L
MARSDEN PA
BERINSTEIN NL
Citation: Aa. Zarrin et al., CLONING AND CHARACTERIZATION OF THE HUMAN RECOMBINATION-ACTIVATING-GENE-1 (RAG1) AND RAG2 PROMOTER REGIONS, The Journal of immunology, 159(9), 1997, pp. 4382-4394
Citation: E. Pizzoferrato et Nl. Berinstein, COMBINATION OF COSTIMULATORY AND CYTOKINE EXPRESSION IN B-CELL LYMPHOMA TO GENERATE ANTITUMOR IMMUNITY, Blood, 90(10), 1997, pp. 2283-2283
Citation: Sc. Tang et al., IMMUNOSUPPRESSIVE TOXICITY OF CAMPATH(R)1H MONOCLONAL-ANTIBODY IN THETREATMENT OF PATIENTS WITH RECURRENT LOW-GRADE LYMPHOMA, Leukemia & lymphoma, 24(1-2), 1996, pp. 93-101
Authors:
FARRUGIA MM
DUAN LJ
REIS MD
NGAN BY
SAWKA CA
BERINSTEIN NL
Citation: Mm. Farrugia et al., SEQUENCE PRESERVATION OF THE 3RD EXON OF THE BCL-2 GENE IN NON-HODGKINS-LYMPHOMA - ABSENCE OF SOMATIC HYPERMUTATION, Leukemia, 9(4), 1995, pp. 643-649
Citation: Nbj. Stiernholm et al., REARRANGEMENT AND EXPRESSION OF THE HUMAN PSI-C-LAMBDA-6 GENE SEGMENTRESULTS IN A SURFACE IG RECEPTOR WITH A TRUNCATED LIGHT-CHAIN CONSTANT-REGION, The Journal of immunology, 154(9), 1995, pp. 4583-4591
Citation: Nbj. Stiernholm et Nl. Berinstein, MUTATED PROMOTER OF A HUMAN IG V-LAMBDA GENE SEGMENT IS ASSOCIATED WITH REDUCED GERM-LINE TRANSCRIPTION AND A LOW-FREQUENCY OF REARRANGEMENT, The Journal of immunology, 154(4), 1995, pp. 1748-1761
Citation: Lk. Verkoczy et al., UP-REGULATION OF RECOMBINATION ACTIVATING GENE-EXPRESSION BY SIGNAL-TRANSDUCTION THROUGH THE SURFACE IG RECEPTOR, The Journal of immunology, 154(10), 1995, pp. 5136-5143
Citation: Nbj. Stiernholm et Nl. Berinstein, IMMUNOGLOBULIN SOMATIC VARIATION - STUDIES OF RECEPTOR EDITING IN A HUMAN B-CELL LYMPHOMA, Leukemia & lymphoma, 12(5-6), 1994, pp. 333-341
Citation: R. Haq et al., SIGNIFICANCE OF A PARTIAL OR SLOW RESPONSE TO FRONT-LINE CHEMOTHERAPYIN THE MANAGEMENT OF INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - A LITERATURE-REVIEW, Journal of clinical oncology, 12(5), 1994, pp. 1074-1084
Citation: Md. Daley et al., IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE GENE UTILIZATION IN HUMAN LARGE-CELL AND BURKITTS-LYMPHOMA CELL-LINES, Clinical and investigative medicine, 17(6), 1994, pp. 522-530
Citation: Nbj. Stiernholm et al., IDENTIFICATION OF A NEW HUMAN V-LAMBDA GENE FAMILY V-LAMBDA-X, The Journal of immunology, 152(10), 1994, pp. 4969-4975
Citation: Nl. Berinstein et al., OBJECTIVE CLINICAL-RESPONSES IN PATIENTS WITH PROGRESSIVE RECURRENT LOW-GRADE LYMPHOMA TREATED WITH CAMPATH(R) 1H MONOCLONAL-ANTIBODY, Blood, 84(10), 1994, pp. 10000638-10000638
Authors:
FARRUGIA MM
DUAN LJ
REIS MD
NGAN BY
BERINSTEIN NL
Citation: Mm. Farrugia et al., ALTERATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN DIFFUSE LARGE-CELL LYMPHOMAS WITH TRANSLOCATIONS OF THE C-MYC AND BCL-2 PROTOONCOGENES, Blood, 83(1), 1994, pp. 191-198
Authors:
BERINSTEIN NL
REIS MD
NGAN BY
SAWKA CA
JAMAL HH
KUZNIAR B
Citation: Nl. Berinstein et al., DETECTION OF OCCULT LYMPHOMA IN THE PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH UNTREATED EARLY-STAGE AND ADVANCED-STAGE FOLLICULAR LYMPHOMA, Journal of clinical oncology, 11(7), 1993, pp. 1344-1352
Citation: Ew. Winquist et al., REACTIVATION AND DISSEMINATION OF BLASTOMYCOSIS COMPLICATING HODGKINS-DISEASE - A CASE-REPORT AND REVIEW OF THE LITERATURE, American journal of hematology, 43(2), 1993, pp. 129-132
Citation: Nbj. Stiernholm et Nl. Berinstein, UP-REGULATED RECOMBINATION-ACTIVATING GENE-EXPRESSION IN SIG- VARIANTS OF A HUMAN MATURE B-CELL LINE UNDERGOING SECONDARY IG-LAMBDA REARRANGEMENTS IN CELL-CULTURE, European Journal of Immunology, 23(7), 1993, pp. 1501-1507